ARCHIVES

Morale, Money Woes Hit MD Anderson

This article is from The Cancer Letter archive.

Vol. 39 No. 03 | January 18, 2013

Download PDF Visit The Full Archive

Related Articles

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

September 6, 2002

Biotheraputics Inc. Markets ‘Custom Made’ Experimental Therapy

August 9, 1985

Lurie Center At Northwestern Wins Core Grant Renewal.

December 7, 2001

DeVita Defends CHP Awards, Says Program Has High Priority

September 5, 1980

The New NCI: Structure, Procedures, Advisory Boards To Change, Klausner Says

September 15, 1995

Sharfstein To Leave FDA

January 7, 2011